{"data":[{"accessionNo":"0001193125-26-349304","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":"K08588103","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"Artisan Partners Asset Management Inc.","reportingCik":null,"personType":"HC","sharesOwned":2634024,"percentOfClass":4.2,"filedAt":"2026-08-13"},{"accessionNo":"0001193125-26-349304","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":"K08588103","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"Artisan Partners Holdings LP","reportingCik":null,"personType":"HC","sharesOwned":2634024,"percentOfClass":4.2,"filedAt":"2026-08-13"},{"accessionNo":"0001193125-26-349304","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":"K08588103","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"Artisan Investments GP LLC","reportingCik":null,"personType":"HC","sharesOwned":2634024,"percentOfClass":4.2,"filedAt":"2026-08-13"},{"accessionNo":"0001193125-26-349304","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":"K08588103","securityClass":"Ordinary Shares","eventDate":"2026-06-30","reportingPerson":"Artisan Partners Limited Partnership","reportingCik":null,"personType":"IA","sharesOwned":2634024,"percentOfClass":4.2,"filedAt":"2026-08-13"},{"accessionNo":"0001274173-26-000131","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA A/S","ticker":"ASND","cusip":"04351P101","securityClass":"American Depositary Shares","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":3719452,"percentOfClass":6,"filedAt":"2026-05-15"},{"accessionNo":"0001562230-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001612042","issuerName":"Ascendis Pharma AS","ticker":"ASND","cusip":"04351P101","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":2013285,"percentOfClass":3.2,"filedAt":"2026-05-14"},{"accessionNo":"0001897612-26-000459","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA A/S - ADR","ticker":"ASND","cusip":"04351P101","securityClass":"ADR","eventDate":"2026-04-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6506219,"percentOfClass":10.5,"filedAt":"2026-05-07"},{"accessionNo":"0001897612-26-000457","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA A/S - ADR","ticker":"ASND","cusip":"04351P101","securityClass":"ADR","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6162042,"percentOfClass":9.9,"filedAt":"2026-05-07"},{"accessionNo":"0000315066-26-001109","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA AS","ticker":"ASND","cusip":"K08588103","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3852100.98,"percentOfClass":6.6,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001109","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA AS","ticker":"ASND","cusip":"K08588103","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3852100.98,"percentOfClass":6.6,"filedAt":"2026-05-06"},{"accessionNo":"0001177719-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Westfield Capital Management Company, L.P.","reportingCik":null,"personType":"IA","sharesOwned":5185696,"percentOfClass":8.48,"filedAt":"2026-02-11"},{"accessionNo":"0001193125-26-035094","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-12-31","reportingPerson":"Artisan Partners Asset Management Inc.","reportingCik":null,"personType":"HC","sharesOwned":3225885,"percentOfClass":5.2,"filedAt":"2026-02-03"},{"accessionNo":"0001193125-26-035094","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-12-31","reportingPerson":"Artisan Partners Holdings LP","reportingCik":null,"personType":"HC","sharesOwned":3225885,"percentOfClass":5.2,"filedAt":"2026-02-03"},{"accessionNo":"0001193125-26-035094","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-12-31","reportingPerson":"Artisan Investments GP LLC","reportingCik":null,"personType":"HC","sharesOwned":3225885,"percentOfClass":5.2,"filedAt":"2026-02-03"},{"accessionNo":"0001193125-26-035094","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-12-31","reportingPerson":"Artisan Partners Limited Partnership","reportingCik":null,"personType":"IA","sharesOwned":3225885,"percentOfClass":5.2,"filedAt":"2026-02-03"},{"accessionNo":"0001274173-25-000281","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA A/S","ticker":"ASND","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":4323059,"percentOfClass":7.8,"filedAt":"2025-11-14"},{"accessionNo":"0001897612-25-000536","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001612042","issuerName":"ASCENDIS PHARMA A/S - ADR","ticker":"ASND","cusip":null,"securityClass":"ADR","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":2667563,"percentOfClass":4.8,"filedAt":"2025-11-14"}],"updatedAt":"2026-10-15T03:18:48.717Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}